BALTIMORE, MD, January 5, 2021 – AsclepiX Therapeutics, Inc., a biopharmaceutical company using computational biology to identify potent peptide regulators of vascular and cellular homeostasis for the treatment of retinal...
Connect with us and get the latest news on how AsclepiX Therapeutics is working to develop life-transforming medicines to make hope a reality for patients in need
New Jersey Office
AsclepiX Therapeutics, Inc.
185 Hudson Street, Suite 2500
Jersey City, New Jersey 07311
Baltimore Office
Corporate Headquarters
301 W 29th Street, Suite 2004,
Baltimore, Maryland 21211
© 2021 AsclepiX Therapeutics. All Rights Reserved. Privacy Policy | Terms of Use